11 results
PRE 14A
HLVX
HilleVax Inc
12 Apr 24
Preliminary proxy
4:05pm
in their certificates of incorporation and failing to adopt the proposed Officer Exculpation Charter Amendment could impact our recruitment and retention of exceptional
10-Q
2022 Q1
HLVX
HilleVax Inc
8 Jun 22
Quarterly report
4:25pm
recruitment or the ability of enrolled subjects to complete the trial or result in potential product liability claims. Undesirable side effects caused … and recruitment and the ability of subjects to continue in clinical trials, result in a decrease in the incidence of norovirus infection among trial
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
severity and prevalence of expected or unexpected side effects. Vaccine-related side effects could affect subject recruitment or the ability of enrolled … research and development activities, impede our clinical trial initiation and recruitment and the ability of subjects to continue in clinical trials, result
S-1/A
crxx6l 34jbj
18 Apr 22
IPO registration (amended)
6:08am
S-1
4jyadg 0ynmvd0pmv1x
6 Apr 22
IPO registration
4:21pm
DRS/A
tzwa043rmd1 6iaigq6
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
3wmqhmt
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next